Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07154186

Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Impact of Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).

Detailed description

Premature coronary artery disease (CAD), defined as CAD occurring before the age of 55 in men and 65 in women, has emerged as a growing health concern worldwide. Insulin resistance and associated metabolic alterations are strongly implicated in premature atherosclerosis. Even in non-diabetic individuals, subclinical insulin resistance promotes endothelial dysfunction, oxidative stress, and low-grade inflammation, leading to early vascular damage. The triglyceride-glucose (TyG) index, calculated using fasting glucose and triglyceride levels, has emerged as a cost-effective surrogate marker for insulin resistance.

Conditions

Interventions

TypeNameDescription
OTHERCoronary Angiographic AssessmentCoronary angiographic assessment will be performed for all patients.

Timeline

Start date
2025-09-04
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-09-04
Last updated
2025-09-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07154186. Inclusion in this directory is not an endorsement.